METTL3 and acute myeloid leukemia: Then, we examined the relationship between METTL3 expression and AML chemoresistance, and found that the expression of METTL3 in most relapse AML patients was increased compared with that at primary diagnosis (GSE83533) (Supplementary Table 2).